Regional Health Properties Reports Third Quarter 2026 Results

Detailed summary
Portfolio Occupancy Reached 76%, an 870-Basis-Point Year-Over-Year ImprovementReported revenue of $25.0 million, an increase of 65.2% compared to third quarter 2025Adjusted EBITDA¹ of $1.2 million, an increase of 365% compared to third quarter 2025 ATLANTA, GA, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc.
ATLANTA, GA, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the "Company," "Regional," "we," "us" or "our") (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ), a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services, today announced its financial results for the third quarter ended September 30, 2026.
Brent Morrison, Regional's President, Chief Executive Officer and Chairman, commented, "We are very pleased with our third quarter results, which reflect continued operating improvements and meaningful progress in our transformation from a traditional healthcare real estate landlord into an integrated healthcare company. Our improving financial performance provides growing evidence that our expanded business model is beginning to deliver on its potential. By taking a more active role in facility operations, we are capturing a greater share of the underlying economics of our healthcare assets while creating additional opportunities to improve operational efficiency and profitability."
Mr. Morrison continued, "While we are encouraged by the operating momentum, we recognize there is more work ahead. Our focus is on improving facility-level profitability, optimizing our Pharmacy and DME operations, and translating stronger operating earnings into sustainable free cash flow. At the same time, we continue to pursue refinancing opportunities that would provide greater financial flexibility to support our operating momentum and strategic growth initiatives."
1 Adjusted EBITDA is a non-GAAP financial measure. See "Use of Non-GAAP Financial Measures" for important additional information.
As of September 30, 2026, the Company had $1.7 million of unrestricted cash and $3.2 million of restricted cash. As of September 30, 2026, the Company had $42.2 million of indebtedness, net of deferred financing costs and unamortized discounts.
Regional Health…
T…
Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)




